期刊文献+

胰腺神经内分泌肿瘤的诊断与外科治疗 被引量:5

Diagnosis and surgical treatment of pancreatic neuroendocrine neoplasms
原文传递
导出
摘要 目的探讨胰腺神经内分泌肿瘤(pNENs)的诊治策略及预后影响因素。方法回顾性分析北京大学第一医院2007年1月至2016年12月经病理证实的44例pNENs患者临床资料,采用Kaplan—Meier法分析患者预后影响因素。结果本组患者肿瘤位于胰头、胰体尾者各22例(50.0%)。无功能性pNENs25例(56.8%),功能性pNENs19例(43.2%)。患者肿瘤手术切除40例。其中胰十二指肠切除14例,胰体尾切除20例,肿瘤单纯切除6例。非根治性手术或未手术4例。肿瘤分级1级23例(52.3%),2级15例(34.1%),3级6例(13.6%);I期23例(52.3%),II期16例(36.4%),III期2例(4.5%),IV期3例(6.8%)。患者总体1、3及5年生存率分别为92.0%、87.0%和72.0%。总生存期(OS)1~119个月,中位生存期119个月。接受根治性手术与否、肿瘤分级、TNM分期、淋巴结转移及远处转移等是影响患者总生存期(OS)的危险因素(P〈0.05)。结论根治性手术切除是pNENs的首选治疗手段。肿瘤分级、TNM分期、淋巴结转移及远处转移等与预后显著相关。 Objective To study the diagnosis, treatment and prognostic factors of pancreatic neuro- endocrine neoplasms (pNENs). Methods The clinical, pathological and follow-up data of 44 patients with pNENs treated at the Peking University First Hospital from Jan. 2007 to Dec. 2016 were retrospectively studied. Survival analysis was performed with the Kaplan-Meier method. Results There were 21 male and 23 female patients. The mean age was (54.8± 14.0) years. 25 patients had non-functional, while 19 had functional pNENs. Curative resection was performed in 40 patients. Neural invasion and intravascular cancer emboli were found in 7 and 5 patients, respectively. The pathologic data showed that the number of patients with G1, G2, G3 were 23(52.3% ), 15(34.1% ), 6( 13.6% ), respectively. The number of patients with stage I , !1, HI, and IV were 23(52.3% ), 16(36.4% ), 2(4.5% ) and 3(6.8% ), respectively. The predictive factors on prognosis included curative resection or not, WHO grade, TNM staging, lymph node metastasis and distant metastasis ( P 〈 0.05 ). Conclusions Curative surgical resection is the first choice of treatment for pNENs. WHO grade, TNM staging, lymph node metastasis and distant metastasis were significantly related to the prognosis of pNENs.
出处 《中华肝胆外科杂志》 CSCD 北大核心 2017年第8期505-508,共4页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金(81672353)
关键词 胰腺神经内分泌肿瘤 危险因素 预后 诊断 外科治疗 Pancreatic neuroendocrine neoplasms Risk factors Prognosis Diagnosis Sur-gical treatment
  • 相关文献

参考文献3

二级参考文献7

  • 1Strosberg J, Gardner N, Kvols L. Survival and prognostic factor a- nalysis of 146 metastatic neuroendocrine tumors of the mid-gut. Neumendocrinology ,2009,89 (4) :471-476.
  • 2Hashim YM, Trinkaus KM, Linehan DC, et al. Regional lymph-adenectomy is indicated in the surgical treatment of pancreatic neu- roendocrine tumors (PNETs). Ann Surg,2014,259 : 197-203.
  • 3Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an interna- tional multi-institutional analysis. Ann Surg Oncol, 2010, 17 (12) :3129-3136.
  • 4Caplin ME, Pavel M, Cwikla JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med, 2014, 371:224-233.
  • 5Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med, 2011,364:501-513.
  • 6Shia J,Tang L H,Weiser M R,王文军(摘译),张帆(审校).非小细胞型胃肠道高级别神经内分泌癌作为独立亚型的病理特征[J].临床与实验病理学杂志,2008,24(4):415-415. 被引量:16
  • 7中国胃肠胰神经内分泌肿瘤病理学诊断共识[J].中华病理学杂志,2011,40(4):257-262. 被引量:291

共引文献178

同被引文献25

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部